Objectives: To investigate fear of legal claims and defensive behaviours among specialists in infectious diseases (ID) and clinical microbiology (CM) and to identify associated demographic and professional characteristics.
Introduction
The alarming spread of antibiotic resistance is greatly concerning and requires a multifaceted approach. 1 Antibiotic use drives bacterial resistance, 2 and antibiotic misuse and overuse remain frequent. 3 Antibiotic prescribing is the result of a complex decision-making process and a thorough understanding of factors influencing and guiding physicians' prescribing behaviours is needed to strengthen antibiotic stewardship (ABS) interventions. 4, 5 Many determinants of inappropriate prescribing behaviour have been described, including the impact of the environmental context, available resources, cultural and social factors, professional interactions and hierarchy, financial and non-financial incentives and disincentives, and legal factors. 5, 6 However, little attention has been paid so far to the possible impact of malpractice liability on antibiotic prescriptions.
Malpractice claims against physicians are quite common in Western countries and in some contexts between 2% and 19% of doctors working in high-risk specialties can face a litigation each year. 7 The stress induced by legal complaints can impact on prescribers' psychological health, causing feelings of concern, uneasiness and anger, and even leading to anxiety, burnout and depression. 8 When physicians perceive litigation as a threat, they may adopt defensive behaviours as a way to reduce the chances of litigation or to ensure a form of defence in the case of malpractice claims. These behaviours usually deviate from evidence-based practice and are known as defensive medicine. This encompasses the tendency to over-prescribe diagnostic examinations and medications, to increase consultations with other physicians as well as referrals to hospitals, and to avoid at-risk patients and procedures, all in order to reduce the likelihood of omissions or errors. Most physicians admit to employing some form of defensive medicine, at least sometimes. [9] [10] [11] Infectious diseases (ID) and clinical microbiology (CM) are not considered as high-risk specialties for malpractice liability, 7, 12 but evidence about the impact of defensive medicine in these fields is lacking, particularly concerning its potential effects on antibiotic prescribing behaviour and ABS programmes. Since overprescription of medications is a common feature of defensive medicine, [9] [10] [11] 13 it is possible the fear of professional liability could be associated with antibiotic overuse, particularly of broadspectrum agents. Defensive medicine among ID and CM specialists may indeed have an impact on ABS programmes, where these specialists act as role models.
The objective of this study was to investigate fear of legal claims and defensive behaviours among specialists in ID and CM, and to identify associated demographic and professional characteristics.
Methods

Survey design and dissemination
AntibioLegalMap was an international cross-sectional exploratory survey conducted from June to August 2016 by the ESCMID Study Group for Antimicrobial stewardshiP (ESGAP). We used a self-administered and internet-based questionnaire hosted on SurveyMonkey V R (Palo Alto, CA, USA). The questionnaire targeted hospital specialists in ID and CM (senior doctors), who prescribe antibiotics and/or advise on antibiotic prescriptions on a daily basis. Pharmacists were not eligible, even though they are key actors in ABS teams, since they do not prescribe antibiotics in most countries.
The questionnaire was developed by a multidisciplinary panel composed of ID physicians, a methodologist and public health specialist and a sociologist, through an informal consensus approach based on a literature review and collective discussion. To assess the questionnaire's clarity, time requirement and applicability in different countries, a pilot version was tested by nine ABS experts selected among the authors' networks, who had combined working experience in 12 European countries.
The survey was broadly advertised using ESCMID's website, newsletter and social media, and the ESGAP network, newsletter and Open Virtual Learning Community. In addition, ESGAP members were invited to raise awareness of the survey in their own professional networks, particularly via national ID or CM societies. At least one reminder was sent in each dissemination channel.
Participation was voluntary and not compensated. The survey was completely anonymous at all stages and no information on the health of respondents was collected, so ethics approval was not required.
Survey structure
The 29-item questionnaire (in English) included four parts (the AntibioLegalMap survey is available as Supplementary data at JAC Online):
(i) filter questions (questions 1-3), aimed at selecting the survey's target population; (ii) respondents' characteristics (questions 4-11); (iii) practices, organization and sharing of legal responsibilities in advising on antibiotic prescription (questions [12] [13] [14] [15] [16] [17] [18] [19] [20] ; and (iv) impact of defensive medicine on antibiotic prescribing and advising on antibiotic prescribing (questions 21-29). Analyses from sections 1, 2 and 4 will be presented in this paper.
Participants' demographic and professional characteristics included specialty, type of employment contract, experience, work setting and participation within an ABS team.
In the section focusing on defensive medicine, three main variables were assessed using Likert-type scales: (i) fear of legal liability when prescribing antibiotics or advising on antibiotic prescriptions; (ii) defensive behaviours in antibiotic prescribing in the home department (the department the participant belonged to); and (iii) defensive behaviours in advising on antibiotic prescriptions outside the home department.
Respondents were asked to rate how often they feared legal liability on a scale of 0 ('never worried about it') to 5 ('always worried'). A 'don't know' option was offered. Answers were grouped in three categories: never worried (score 0); sometimes worried (score 1-2); and often worried (score [3] [4] [5] .
Six potential defensive behaviours in antibiotic prescribing/advising were assessed: prescribing antibiotics even if not really necessary; prescribing unnecessarily broad-spectrum antibiotics or combinations of agents; avoiding switching to oral treatments; prolonging antibiotic durations; treating bacterial colonization; and prescribing an antibiotic because of a patient's perceived expectation. Respondents were invited to declare if, and how frequently (rarely, sometimes, often), they engaged in each defensive behaviour, because of fear of legal liability. A 'don't know' option was also provided.
A defensive score was calculated for each respondent for both antibiotic prescribing and advising on antibiotic prescribing. Points were attributed based on how frequently each of the six defensive behaviours was used: 0 points for never, 1 for rarely, 2 for sometimes and 3 for often. Defensive scores ranged from 0 (people never applying any of the defensive behaviours) to 18 (people often applying all of the six defensive behaviours).
Respondents who admitted to engaging in any of the defensive behaviours (i.e. having a defensive score 1) were asked to indicate which conditions they felt favoured defensive practices, from a list of potential situations. Finally, a list of possible actions or conditions to reduce defensive behaviours was provided and all participants were asked to identify those that they thought would be most useful in their circumstances.
Statistical analysis
Participants' demographic and professional characteristics, fear of legal liability, defensive behaviours, favouring conditions and proposed solutions are presented as numbers and percentages.
A two-step analysis was applied to describe the association between a set of factors (listed afterwards) and the three following variables: (i) fear of legal liability in antibiotic prescribing or advising on antibiotic prescribing (often worried versus never worried); (ii) defensive behaviours in antibiotic prescribing [defensive score 4 (median) versus ,4]; and (iii) defensive behaviours in advising on antibiotic prescribing [defensive score 3 (median) versus ,3]. The factors investigated were: specialty (ID, CM); gender; area of origin (five most represented countries and others grouped together); age class (35, 36-50, .50 years); work setting (university public hospital, other public facility, private facility); type of employment contract (fixedterm contract, permanent employment); participation in an ABS team (yes, no); being aware of previous cases of litigation in the institution in the last 5 years related to antibiotic prescribing or advising (yes, no); and personal experience with litigation related to antibiotic prescribing or advising (yes, no). Fear of legal liability was also included as a potential factor associated with defensive behaviours. Factors reaching a threshold of P 0.20 in bivariate logistic regression models were introduced in multivariable logistic Tebano et al.
regression models. Duration of professional experience was not considered in the multivariate step because of collinearity with age. Significance was fixed at a 0.05 and two-sided tests were used.
Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
Study sample and experience with litigation
A total of 830 individuals from 74 countries participated in the survey ( Figure S1 , available as Supplementary data at JAC Online). The five most represented countries were Germany (115/823 participants, 14.0%), the UK (78/823, 9.5%), France (71/823, 8.6%), Spain (61/823, 7.4%) and Italy (50/823, 6.1%). Table 1 illustrates participants' demographic and professional characteristics. A minority of respondents (12.7%, 98/774) were aware of previous cases of litigation in their institution in the last 5 years related to antibiotic prescribing or advising on antibiotic prescribing. They reported 43 cases related to prescribing antibiotics in the home department and 88 cases related to advising on antibiotics outside the home department.
Few participants (6.7%, 52/779) had personal experience of litigation related to antibiotic prescribing or advising, and among these only 3 (5.8%) reported having consequently had any kind of condemnation (e.g. official censure or conviction), i.e. 0.4% of the total population (3/779).
Fear of legal liability in antibiotic prescribing or advising on antibiotic prescribing
A fifth of respondents (21.2%, 164/774) reported that they were never worried when they prescribe antibiotics or advise on antibiotic prescriptions, 45.1% (349/774) were sometimes worried (score 1-2) and 28.6% (221/774) were often worried (score 3-5).
The results of bivariate analyses are presented in Table S1 . In the multivariable analysis, four factors were independently associated with being often worried about liability (Table 2) : female gender; young age (35 years); coming from Italy, the UK or countries other than France, Germany or Spain; and being aware of cases of litigations.
Defensive behaviours in antibiotic prescribing in the home department
Fifteen percent of participants (93/618) reported that they never apply any kind of defensive behaviour in antibiotic prescribing in the home department, while the remaining 85.0% (525/618) admitted to adopting some form of defensive behaviours. The most frequent defensive behaviours reported were prolonging antibiotic treatment durations, prescribing unnecessarily broadspectrum antibiotics or combinations of agents and prescribing unnecessary antibiotic treatments (Figure 1) .
The results of bivariate analyses are presented in Table S2 . In the multivariable analysis, three factors were independently associated with using defensive behaviours more frequently than the median of the respondents (Table 3) : age 50 years; coming from Germany or countries other than France, Italy, Spain and the UK; and being sometimes or often worried about legal liability. Twenty-four percent of participants (156/661) declared never engaging in defensive behaviours when advising on antibiotic prescriptions outside the home department, while 76.4% (505/661) reported adopting some form of defensive behaviours. Again, the most frequently reported defensive behaviours were prolonging antibiotic treatment durations, prescribing unnecessarily broadspectrum antibiotics or combinations of agents and prescribing unnecessary antibiotic treatments (Figure 1) . The results of bivariate analyses are listed in Table S2 . In multivariate analysis, being sometimes or often worried about legal liability was independently associated with engaging in defensive behaviours more frequently than the median of the respondents (Table 3) .
Situations favouring defensive behaviours and possible solutions
Concerning antibiotic prescription, 37.7% of respondents (126/334) reported being more likely to act defensively when prescribing to inpatients and 36.8% (123/334) when prescribing to outpatients.
Working at night was cited as a situation favouring defensive behaviours (alone or associated with the aforementioned conditions) by 31.1% of respondents (104/334).
Defensive behaviours in advising on antibiotic prescribing were considered more likely to occur when there is a poor collaboration with the physicians asking for advice and/or when the piece of advice is given without direct patient examination [60.0% (256/427) and 47.5% (203/427) of respondents, respectively].
Respondents reported that the most desirable actions or conditions that could help to reduce defensive behaviours in antibiotic prescribing were having local guidelines and/or decisional algorithms that could guide and support the decision-making process (453/608, 74.5%), working as a team to benefit from other colleagues' competences and share responsibilities (463/608, 76.2%), and having more time to dedicate to each prescription or piece of advice (336/608, 55.3%).
Discussion
In this exploratory survey three-quarters of specialists in ID and CM reported that they were at least sometimes worried about legal liability when they prescribe antibiotics or when they give advice to others on antibiotic prescribing. At the same time, litigation related to these medical practices was experienced by only a small minority of respondents and condemnations remained extremely rare. Many respondents acknowledged that they can revert to some defensive behaviours when they prescribe antibiotics or advise on antibiotic prescribing (85% and 76%, respectively) and the frequency of defensive behaviours was significantly influenced by the fear of legal liability. The most commonly acknowledged defensive practices, irrespective of whether prescribing antibiotics or advising on prescribing, were prolonging antibiotic duration, prescribing unnecessarily broad-spectrum antibiotics or combinations of agents and prescribing unnecessary antibiotic treatments. These practices constitute a form of defensive medicine and could be a hidden driver of antibiotic misuse and overuse. Furthermore, these findings have relevance for ABS programmes in which specialists in CM and ID act as role models and influence other prescribers, particularly if the defensive behaviours are contrary to the stewardship actions they advocate.
The practice of defensive medicine is quite common, both in hospital and primary care settings, with previous studies finding that up to 70%-90% of physicians acknowledge engaging in some defensive behaviours. [11] [12] [13] Defensive medicine is particularly common in surgical specialties and other specialties considered at high risk for malpractice liability, 7 but still commonly occurs in medical specialties where there is less risk of claims. 11, 14 There is strong evidence on some direct consequences of defensive medicine, such as financial burden, but its real impact on the quality of healthcare remains to be fully explored. 9, 15 Our survey suggests that defensive medicine can have a role in the complex decision-making process involved in antibiotic prescribing, being a relatively hidden determinant of deviation from evidencebased practice. Two recent qualitative studies 16, 17 explored this concept, but no studies focused on specialists in CM and ID, or ABS teams, to the best of our knowledge.
Defensive medicine is the result of different drivers. Liability laws that exist in many countries produce contexts where litigation is common. This is considered to favour defensive medicine Years of professional experience were excluded from this analysis, because of high collinearity with age.
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practices, without necessarily increasing the probability that patients are rightly compensated if they are victims of malpractice. 18, 19 Physicians' prescribing practices also have to be interpreted as part of a wider framework defining professional behaviour. As with any public behaviour, this is necessarily influenced by the cultural environment, resulting in social norms. 20 It has been argued 21, 22 that the diffuse cultural perception of modern medicine as a perfect science can make people consider medical errors/omissions as a deviation from the correct practice in any situation. This can produce in the public, as well as in doctors, an intolerance of error and a culture of blame, according to Hoffman and Kanzaria. 21 Errors might then lead to shame and consequently Defensive medicine among antibiotic stewards JAC some doctors prefer to act defensively, 22 explaining why fear and defensive behaviours are not necessarily bound to a real legal threat.
Antibiotic overuse is an interesting example of this dynamic, since the professional stress related to a patient-based perceived risk (the possible omission of a necessary antibiotic treatment) also needs to be balanced with a wider and not immediate populationbased risk (the spread of bacterial resistance). 20, 23, 24 Moreover, antibiotics are usually considered as safe drugs and often little attention is paid at the level of an individual prescription to the risk of side effects (including antibiotic resistance), compared with the (perceived or real) consequences of the omission of a treatment. 20, 23 The findings of this survey showed that malpractice liability is perceived as a threat by most specialists in ID and CM even if this situation has never been personally experienced and if condemnations are exceedingly rare. As might be expected, fear of liability was associated with awareness of cases of litigations concerning someone else; however, the fear of negative consequences deriving from medical error or misconduct in this context may be disproportionately high.
We identified specific characteristics that were significantly associated with a higher fear of liability and more frequent defensive behaviours (Tables 2 and 3 ). Female gender was associated with a higher fear of liability. However, gender was not associated with a different frequency of defensive practices, confirming the conclusions of previous studies. 10, 11, 14 Younger age was associated both with fear and defensive behaviours in antibiotic prescribing. Younger physicians are likely to have had less experience in their profession, which may explain the higher fear and defensive practices in this subgroup. Moreover, as suggested elsewhere, 11 older physicians may be more confident in estimating the true likelihood of professional liability, since in their experience ultimately claims rarely affect physicians.
Working in specific countries was also associated with both fear and defensive behaviours in antibiotic prescribing. The variations seen between countries may be due to differences in professional environments and the legal system. 9 These findings must be interpreted with caution, due to the exploratory nature of this survey, and deserve further investigation. We are planning to work with law specialists to explore the legal framework related to antibiotic prescribing/advising in a sample of European countries.
The measures perceived as being the most useful by respondents for reducing defensive behaviours in antibiotic prescribing or advising were sharing of responsibilities, availability of guidelines Median defensive score in advising on antibiotic prescription. c Years of professional experience were excluded from this analysis, because of high collinearity with age.
and decision algorithms, and availability of time, i.e. workforce. This emphasizes some of the cornerstones of ABS activity, particularly the need for a team dedicated to ABS within most institutions. 25 It has been shown that understaffing of specialists in ID and CM is common in many countries 26 and an increase in human resources dedicated to stewardship has been advocated. 27, 28 This exploratory survey has some limitations. Due to its international dissemination, the questionnaire was only in English, representing a possible barrier for some respondents. Participation was voluntary, thus respondents might not be representative of all specialists in ID and CM. Furthermore, as already underlined by Studdert et al., 12 self-assessment of defensive practices is challenging for different reasons: respondents could have difficulties defining and distinguishing what can be identified as inappropriate prescriptions; and it can be challenging to discriminate liabilityrelated influence on prescription from other factors, such as a more general fear of being wrong or being blamed by colleagues or patients, or anxiety related to diagnostic and clinical uncertainty. Nonetheless, surveys remain the instrument most frequently used in the scientific literature to investigate defensive medicine practices and we believe that the relevant questions were sufficiently explicit to minimize the risk of misinterpretation. Finally, the sensitive nature of many questions may have led some participants to give socially desirable answers, even if the anonymity might have limited this.
In conclusion, our study suggests that defensive medicine related to antibiotic prescribing/advising exists and should be further investigated as a potential determinant of antibiotic misuse. Most specialists in ID and CM reported that they had sometimes engaged in some form of defensive behaviour in prescribing or advising on antibiotic prescription and this was associated with fear of legal liability. Defensive medicine should then be considered when implementing ABS programmes. Further studies are needed to quantify the occurrence of defensive behaviours and to assess the impact of these behaviours on antibiotic prescriptions. Future studies should also attempt to elucidate what triggers fear of liability, and to explore the psychological and behavioural mechanisms linking fear to different defensive practices.
